本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Scpharmaceuticals Inc.

3.97
-0.0700-1.73%
盘后3.970.00000.00%13:01 EDT
成交量:18.45万
成交额:74.63万
市值:2.10亿
市盈率:-2.11
高:4.14
开:4.04
低:3.97
收:4.04
数据加载中...
2024/07/03

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/20

SEC问询函

Form CORRESP - Correspondence
2024/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/13

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]